Apnimed posts first set of Phase 3 sleep apnea results, aims for approval filing in 2026
Apnimed's oral drug met the efficacy bar in the first of two Phase 3 studies in obstructive sleep apnea, the biotech said Monday morning. The biotech plans to report results from a second Phase 3 ...
Apnimed's oral drug met the efficacy bar in the first of two Phase 3 studies in obstructive sleep apnea, the biotech said Monday morning.
The biotech plans to report results from a second Phase 3 ...
